PDCD1 and neoplasm: Once the tumor cells are detected by the T cells, the overexpressed PD-L1/2 from the tumor cells engages with PD-1 on the T cells, and the physiological inhibitory pathways will therefore be hijacked by the tumor cells to escape the host immune surveillance system (Huang et al., 2021).